TCBP Non Current Liabilities Total vs Total Assets Analysis
| TCBP Stock | USD 0.60 0.04 6.25% |
TC BioPharm financial indicator trend analysis is much more than just breaking down TC BioPharm Holdings prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether TC BioPharm Holdings is a good investment. Please check the relationship between TC BioPharm Non Current Liabilities Total and its Total Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TC BioPharm Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Non Current Liabilities Total vs Total Assets
Non Current Liabilities Total vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of TC BioPharm Holdings Non Current Liabilities Total account and Total Assets. At this time, the significance of the direction appears to have very week relationship.
The correlation between TC BioPharm's Non Current Liabilities Total and Total Assets is 0.2. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Total Assets in the same time period over historical financial statements of TC BioPharm Holdings, assuming nothing else is changed. The correlation between historical values of TC BioPharm's Non Current Liabilities Total and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of TC BioPharm Holdings are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Non Current Liabilities Total i.e., TC BioPharm's Non Current Liabilities Total and Total Assets go up and down completely randomly.
Correlation Coefficient | 0.2 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Non Current Liabilities Total
Total Assets
Total assets refers to the total amount of TC BioPharm assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in TC BioPharm Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Most indicators from TC BioPharm's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into TC BioPharm Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TC BioPharm Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. As of 11/30/2024, Tax Provision is likely to drop to about (1.1 M). In addition to that, Selling General Administrative is likely to drop to about 5.1 M
| 2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 812.0K | 762.5K | 630.1K | 638.0K | Interest Income | 33.0 | 2.2K | 2.0K | 1.9K |
TC BioPharm fundamental ratios Correlations
Click cells to compare fundamentals
TC BioPharm Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with TC BioPharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if TC BioPharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will appreciate offsetting losses from the drop in the long position's value.Moving together with TCBP Stock
Moving against TCBP Stock
| 0.83 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
| 0.81 | GILD | Gilead Sciences | PairCorr |
| 0.78 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
| 0.71 | VTRS | Viatris | PairCorr |
| 0.69 | EWTX | Edgewise Therapeutics | PairCorr |
The ability to find closely correlated positions to TC BioPharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace TC BioPharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back TC BioPharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling TC BioPharm Holdings to buy it.
The correlation of TC BioPharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as TC BioPharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if TC BioPharm Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for TC BioPharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for TCBP Stock Analysis
When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.